| Lastest Insider Transactions Of Lyell Immunopharma, Inc. ( LYEL ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| LYEL | Lyell Immunopharma, Inc. | Seely Lynn | President and CEO | 2026-05-11 | Sell | 388 | 18.91 | 7,337 | 2026-06-15 18:37:17 |
| LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | Chief Scientific Officer | 2026-05-11 | Sell | 130 | 18.92 | 2,460 | 2026-06-15 18:35:24 |
| LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | Chief Operating Officer | 2026-05-11 | Sell | 89 | 18.92 | 1,684 | 2026-06-15 18:34:03 |
| LYEL | Lyell Immunopharma, Inc. | Bulis Veronica Sanchez | VP, Corporate Controller | 2026-05-11 | Sell | 217 | 18.91 | 4,103 | 2026-06-15 18:32:20 |
| LYEL | Lyell Immunopharma, Inc. | Shook David | Chief Medical Officer | 2026-06-10 | Sell | 1,977 | 12.64 | 24,989 | 2026-06-11 16:07:50 |
| LYEL | Lyell Immunopharma, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | 2026-03-06 | Buy | 488,090 | 25.61 | 12,499,985 | 2026-03-09 16:36:20 |
| LYEL | Lyell Immunopharma, Inc. | ARCH Venture Fund XIII, L.P. | 10% Owner | 2026-03-06 | Buy | 488,090 | 25.61 | 12,499,985 | 2026-03-09 16:34:54 |
| LYEL | Lyell Immunopharma, Inc. | Seely Lynn | President and CEO | 2026-02-11 | Sell | 7,455 | 23.39 | 174,372 | 2026-02-12 20:47:49 |
| LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | Chief Operating Officer | 2026-02-11 | Sell | 1,236 | 23.39 | 28,910 | 2026-02-12 20:46:32 |
| LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | Chief Scientific Officer | 2026-02-11 | Sell | 1,671 | 23.39 | 39,085 | 2026-02-12 20:44:57 |
| LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | Chief Operating Officer | 2026-02-09 | Sell | 109 | 23.12 | 2,520 | 2026-02-11 21:05:21 |
| LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | Chief Scientific Officer | 2026-02-09 | Sell | 147 | 23.12 | 3,399 | 2026-02-11 21:04:20 |
| LYEL | Lyell Immunopharma, Inc. | Seely Lynn | President and CEO | 2026-02-09 | Sell | 438 | 23.12 | 10,127 | 2026-02-11 21:03:03 |
| LYEL | Lyell Immunopharma, Inc. | Bulis Veronica Sanchez | VP, Corporate Controller | 2026-02-10 | Sell | 254 | 23.12 | 5,872 | 2026-02-11 21:00:26 |
| LYEL | Lyell Immunopharma, Inc. | Bulis Veronica Sanchez | VP, Corporate Controller | 2025-12-24 | Sell | 2,072 | 35.80 | 74,181 | 2026-01-06 16:02:57 |
| LYEL | Lyell Immunopharma, Inc. | Seely Lynn | President and CEO | 2025-11-10 | Sell | 412 | 16.11 | 6,637 | 2025-11-12 20:36:42 |
| LYEL | Lyell Immunopharma, Inc. | Bulis Veronica Sanchez | VP, Corporate Controller | 2025-11-10 | Sell | 239 | 16.10 | 3,848 | 2025-11-12 20:34:59 |
| LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | Chief Scientific Officer | 2025-11-10 | Sell | 138 | 16.16 | 2,230 | 2025-11-12 20:33:30 |
| LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | Chief Operating Officer | 2025-11-10 | Sell | 95 | 16.12 | 1,531 | 2025-11-12 20:31:56 |
| LYEL | Lyell Immunopharma, Inc. | Seely Lynn | President and CEO | 2025-08-20 | Sell | 7,257 | 10.54 | 76,518 | 2025-08-22 16:07:24 |
| LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | Chief Operating Officer | 2025-08-20 | Sell | 1,004 | 10.54 | 10,586 | 2025-08-22 16:06:04 |
| LYEL | Lyell Immunopharma, Inc. | Newton Charles W. | Chief Financial Officer | 2025-08-20 | Sell | 1,453 | 10.54 | 15,320 | 2025-08-22 16:03:25 |
| LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | Chief Scientific Officer | 2025-08-20 | Sell | 1,453 | 10.54 | 15,320 | 2025-08-22 16:02:06 |
| LYEL | Lyell Immunopharma, Inc. | Seely Lynn | President and CEO | 2025-08-11 | Sell | 797 | 10.43 | 8,313 | 2025-08-13 21:10:46 |
| LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | Chief Operating Officer | 2025-08-11 | Sell | 185 | 10.43 | 1,930 | 2025-08-13 21:09:33 |
| LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | Chief Scientific Officer | 2025-08-11 | Sell | 267 | 10.43 | 2,785 | 2025-08-13 21:08:15 |
| LYEL | Lyell Immunopharma, Inc. | Newton Charles W. | Chief Financial Officer | 2025-08-11 | Sell | 267 | 10.43 | 2,785 | 2025-08-13 21:06:02 |
| LYEL | Lyell Immunopharma, Inc. | BRAWLEY OTIS W | Directior | 2025-03-31 | Buy | 35,640 | 0.56 | 19,958 | 2025-04-02 15:46:01 |
| LYEL | Lyell Immunopharma, Inc. | Ramachandra Sumant | Directior | 2025-03-21 | Buy | 200,000 | 0.58 | 115,220 | 2025-03-25 18:46:17 |
| LYEL | Lyell Immunopharma, Inc. | Klausner Richard | Directior | 2025-03-14 | Buy | 158,000 | 0.60 | 94,942 | 2025-03-18 20:07:51 |
| LYEL | Lyell Immunopharma, Inc. | Newton Charles W. | Chief Financial Officer | 2025-03-17 | Buy | 200,000 | 0.56 | 111,620 | 2025-03-18 19:01:35 |
| LYEL | Lyell Immunopharma, Inc. | Seely Lynn | President and CEO | 2025-03-14 | Buy | 175,000 | 0.61 | 106,190 | 2025-03-18 18:59:18 |
| LYEL | Lyell Immunopharma, Inc. | Klausner Richard | Directior | 2023-08-15 | Sell | 58,020 | 2.28 | 132,286 | 2023-08-17 16:23:14 |